Skip to content

13F-HR filed by RENAISSANCE TECHNOLOGIES LLC

RENAISSANCE TECHNOLOGIES LLC filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-13, with 4,032 holding rows worth $85,212,489,000.

Accession
0001037389-22-000223
Filed
2022-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 4,032 entries on the cover page, a total value of $85,212,489,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $85,212,518,000 with VALUE read as thousands by filing date, 13F file number 028-06262. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PALATIN TECHNOLOGIES INC696077403COM PAR $ .0146,500$21,000thousands by filing date
TINGO GROUP INC55328R109COM33,800$21,000thousands by filing date
SONIM TECHNOLOGIES INC83548F200COM NEW24,071$21,000thousands by filing date
ZHONGCHAO INCG9897X107CL A15,600$21,000thousands by filing date
KUBIENT INC COM USD0.0000150116V107COM11,700$20,000thousands by filing date
GEE GROUP INC36165A102COM34,200$19,000thousands by filing date
AESTHETIC MED INTL HLDG GR L00809M104ADR11,900$19,000thousands by filing date
MEIWU TECHNOLOGY COMPANY LTDG9604C107ORD SHS21,300$19,000thousands by filing date
CALYXT INC13173L107COM17,900$19,000thousands by filing date
LIPOCINE INC NEW53630X104CMN14,100$19,000thousands by filing date
COMPASS THERAPEUTICS INC20454B104COM13,300$18,000thousands by filing date
ASPEN GROUP INC04530L203COM NEW11,100$18,000thousands by filing date
UNIVERSE PHARMACEUTICALS INCG9442G104SHS14,220$18,000thousands by filing date
AXE COMPUTE INC COM NEW74039M200Stock15,100$15,000thousands by filing date
EXCELLON RES INC F30069C801FOREIGN CANADIAN16,500$15,000thousands by filing date
NEOVASC INC64065J304COM35,411$15,000thousands by filing date
SUPERCOM LTD NEWM87095119SHS NEW26,500$15,000thousands by filing date
EVOKE PHARMA INC30049G104COM28,200$14,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365A309COMMON STOCK11,900$13,000thousands by filing date
SENTAGE HOLDINGS INCG8062B106ORD SHS12,400$13,000thousands by filing date
36KR HOLDINGS INC SPONSORED ADR88429K103ADR10,800$12,000thousands by filing date
9F INC SPON ADS NEW65442R109ADR13,700$12,000thousands by filing date
ZW DATA ACTION TECHNOLOGS IN98880R109COM16,600$12,000thousands by filing date
CHINA INDEX HLDGS LTD16954W101SPNSRD ADS A10,800$11,000thousands by filing date
QUHUO LTD74841Q100ADS18,301$11,000thousands by filing date
BOQII HLDG LTD09950L104SPONSORED ADS24,400$11,000thousands by filing date
ADITX THERAPEUTICS INC007025109COM20,266$9,000thousands by filing date
SENESTECH INC81720R208COM NEW12,382$9,000thousands by filing date
VTV THERAPEUTICS INC CL A918385105Stock11,456$8,000thousands by filing date
EXELA TECHNOLOGIES INC30162V409COM NEW17,755$7,000thousands by filing date
UCOMMUNE INTERNATIONAL LTDG9449A100COM22,100$7,000thousands by filing date
EVOFEM BIOSCIENCES INC30048L104COM18,397$6,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001037389-22-000223this filing2022-05-13acceptance time not in the bulk data set